SEC Filing Summary for J. Erik Fyrwald

J. Erik Fyrwald, a director at Eli Lilly & Co, acquired 8.6465 shares of common stock on July 20, 2026, at a price of $1146.9 per share. These shares were acquired through the Lilly Directors' Deferral Plan in lieu of cash compensation and will be settled in shares following his separation from service. Post-transaction, Fyrwald holds 75409.7433 shares.